Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy
Endocrinology, Diabetes & Metabolism · 2023-07 · 6 (4)
DOI: 10.1002/edm2.434 ↗At a glance
Journal article in Endocrinology, Diabetes & Metabolism, published online on 2023-06-16. Written by Hiba-Allah Chatti and 9 co-authors. Institution: Department of Endocrinology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia. Major MEDLINE topics: Thyroid Nodule, Thyroid Neoplasms. Cited 7 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Introduction
Several ultrasound scoring systems have been developed to stratify the risk of malignancy of thyroid nodules, including ACR (American College of Radiology) and EU (European) TI‐RADS. This study aimed to assess the diagnostic performance of these two classifications using histology as a reference standard.
Methods
It was a single‐centre, retrospective study including 156 patients who underwent thyroidectomy. Ultrasound data of 198 nodules (99 malignant nodules and 99 benign nodules) were analysed. Both classifications were applied for all nodules.
Results
Ultrasound criteria associated with malignancy were solid composition (OR=7.81; p < 10 −3 ), hypoechoic character (OR=16.42; p < 10 −3 ), irregular contours (OR=7.47; p < 10 −3 ), taller‐than‐wide shape (OR=3.58; p = 0.02), microcalcifications (OR=3.02; p = .006) and the presence of cervical adenopathy (OR=3.89; p = .006). The prevalence of malignancy was 15.5%, 69% and 76.9% for EU TI‐RADS categories 3, 4 and 5, respectively. It was 33.3%, 57% and 91.1% for ACR TI‐RADS categories 3, 4 and 5, respectively. For category 5, EU TI‐RADS and ACR TI‐RADS had sensitivities of 60% and 41%, specificities of 82% and 96%, respectively. For categories 4 and 5 combined, the diagnostic performance of these two classification systems became comparable with a sensitivity of 89% and 86% for EU‐TIRADS and ACR‐TIRADS, respectively. The area under the ROC curve was 0.81 for the EU TI‐RADS classification and 0.82 for the ACR TI‐RADS classification.
Conclusions
EU TI‐RADS and ACR TI‐RADS scoring systems seem to be comparable in predicting malignancy in thyroid nodules.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Endocrinology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
- Department of Oto-Rhino-laryngology, La Rabta university Hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
- Department of Radiology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
- Department of Pathology, La Rabta university hospital, Faculty of medicine, University of Tunis-El Manar, Tunis, Tunisia.
ORCID profiles: Ibtissem Oueslati, Meriem Yazidi
Cite
APA
Chatti, H. A., Oueslati, I., Azaiez, A., Marrakchi, J., Boukriba, S., Mizouni, H., Haouet, S., Besbes, G., Yazidi, M., & Chihaoui, M. (2023). Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy. Endocrinology, Diabetes & Metabolism, 6(4). https://doi.org/10.1002/edm2.434
Vancouver
Chatti HA, Oueslati I, Azaiez A, Marrakchi J, Boukriba S, Mizouni H, et al. Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy. Endocrinology, Diabetes & Metabolism. 2023;6(4). doi:10.1002/edm2.434
BibTeX
@article{Chatti2023,
author = {Chatti, Hiba-Allah and Oueslati, Ibtissem and Azaiez, Aymen and Marrakchi, Jihen and Boukriba, Seif and Mizouni, Habiba and Haouet, Slim and Besbes, Ghazi and Yazidi, Meriem and Chihaoui, Melika},
title = {Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2023},
volume = {6},
number = {4},
doi = {10.1002/edm2.434}
}
EUVIMED